Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Lumexa Imaging announced the appointment of Kyle Lynch as Chief Growth Officer to lead enterprise growth strategy through joint ventures, acquisitions, and geographic expansion. Lynch, formerly SVP of Strategy and Development at SCA Health, will oversee growth initiatives and lead the Sales Center of Excellence. The company operates over 185 outpatient imaging centers across 13 states with approximately 5,000 team members.

04/20/2026, 7:00 AM • GlobeNewswire

Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in Lumexa Imaging Holdings, On Holding AG, and MillerKnoll. The investigations were prompted by significant stock price declines following financial disclosures on March 26, 2026. Investors who suffered losses are encouraged to contact the firm.

03/26/2026, 6:55 PM • GlobeNewswire

On Holding AG Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in On Holding AG, Lumexa Imaging Holdings, and MillerKnoll. The investigation into On Holding was triggered by a March 25, 2026 announcement of organizational restructuring, including the appointment of co-founders as Co-CEOs and the stepping down of the current CEO, which resulted in a stock price decline.

03/26/2026, 6:50 PM • GlobeNewswire

Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance

Lumexa Imaging reported strong Q4 2025 results with consolidated revenues of $267.7 million (up 7.9%) and Adjusted EBITDA of $63.8 million (up 18.6%). For full year 2025, the company achieved $1.023 billion in revenues (up 7.8%) and $230.2 million in Adjusted EBITDA (up 14.6%). The company reduced leverage by two turns to 3.5x and opened a record number of de novo centers. For 2026, Lumexa reiterated guidance of $1.045-$1.097 billion in revenues and $234-$242 million in Adjusted EBITDA.

03/26/2026, 6:00 AM • GlobeNewswire

Lumexa Imaging Announces Participation in Upcoming Investor Conferences

Lumexa Imaging Holdings (NASDAQ: LMRI), a major outpatient imaging services provider, announced that CEO Caitlin Zulla and CFO Tony Martin will participate in three upcoming investor conferences in March 2026: Raymond James Institutional Investors Conference (March 2), Leerink Partners Global Healthcare Conference (March 9), and Barclays 28th Annual Global Healthcare Conference (March 10). The company operates over 185 imaging centers across 13 states with approximately 5,000 employees.

02/17/2026, 7:30 AM • Benzinga